VCNX Chart
About

Vaccinex, Inc., a clinical-stage biotechnology company, engages in the discovery and development of targeted biotherapeutics to treat cancer, neurodegenerative diseases, and autoimmune disorders. The company's lead drug candidate is pepinemab, a humanized monoclonal antibody that binds and blocks the activity of SEMA4D. It is developing Pepinemab, which is in phase 2 clinical for the treatment of Alzheimer's disease and has completed phase 2 study for the treatment of Huntington's disease; Pepinemab in combination with Pembrolizumab in phase 2 study for head and neck cancer; Pepinemab in combination with Avelumab in phase 2 study for pancreatic cancer, and completed phase 2 clinical trial with Avelumab for non-small cell lung cancer; and Pepinemab in combination with Nivolumab and/or Ipilimumab which is in phase 2 clinical trial for melanoma; Pepinemab in combination with Trastuzumab and dendritic cell vaccines in phase 2 clinical trial for breast cancer. The company has also developed ActivMAb, a human antibody discovery platform based on a novel method for expressing and presenting complex multipass membrane proteins, as well as full-length human monoclonal antibodies on the surface of mammalian pox viruses. In addition, it develops CHS-114 and anti-CCR8 antibody; and VX5, which is in preclinical development to treat related to autoimmune disorders.It has collaborations with Merck Sharp & Dohme; Ares Trading S.A.; Emory University; Huntington Study Group; Catalent Pharma Solutions, LLC; and Surface Oncology, Inc. The company was incorporated in 2001 and is headquartered in Rochester, New York.

Fundamentals
Scroll to Statements
Sector Healthcare Industry Biotechnology Market Cap 2.76M
Enterprise Value 3.34M Income -18.63M Sales 601.00K
Book/sh -1.55 Cash/sh 0.41 Dividend Yield —
Payout 0.00% Employees 23 IPO —
P/E — Forward P/E -7.36 PEG —
P/S 4.59 P/B -0.66 P/C —
EV/EBITDA -0.18 EV/Sales 5.56 Quick Ratio 0.38
Current Ratio 0.50 Debt/Eq — LT Debt/Eq —
EPS (ttm) -8.88 EPS next Y -0.14 EPS Growth —
Revenue Growth — Earnings 2021-08-16 08:00 ROA -3.76%
ROE — ROIC — Gross Margin 0.00%
Oper. Margin -15.90% Profit Margin 0.00% Shs Outstand 2.68M
Shs Float 1.18M Short Float 3.23% Short Ratio 0.60
Short Interest — 52W High 1.50 52W Low 0.25
Beta 0.69 Avg Volume 3.65K Volume 1.00
Target Price — Recom None Prev Close $1.03
Price $1.03 Change 0.00%
Valuation Models

Price estimates from analyst targets and simple models.

1. Analyst consensus
—
Mean price target
2. Current target
$1.03
Latest analyst target
3. DCF / Fair value
$-77.63
Simplified: (Free Cash Flow ÷ Shares) × 18 (P/FCF multiple). Not a …
Ratings
Current target
$1.03
Low
—
High
—
Mean
—
Insider Transactions
Date Shares Value Url Text Insider Position Transaction Start Date Ownership
0 30756 99957 — Stock Award(Grant) at price 3.25 per share. FRIEDBERG ALBERT D Director and Beneficial Owner of more than 10% of a Class of Security — 2024-11-14 00:00:00 I
1 46153 149997 — Stock Award(Grant) at price 3.25 per share. ZAUDERER MAURICE Chief Executive Officer — 2024-11-14 00:00:00 I
2 240009 1352691 — Conversion of Exercise of derivative security at price 5.64 per share. FRIEDBERG ALBERT D Director and Beneficial Owner of more than 10% of a Class of Security — 2024-09-18 00:00:00 I
3 113650 640531 — Conversion of Exercise of derivative security at price 5.64 per share. ZAUDERER MAURICE Chief Executive Officer — 2024-09-18 00:00:00 I
4 100 451 — Purchase at price 4.51 per share. FRIEDBERG ALBERT D Director and Beneficial Owner of more than 10% of a Class of Security — 2024-08-09 00:00:00 I
5 6406 30349 — Purchase at price 4.60 - 4.92 per share. FRIEDBERG ALBERT D Director and Beneficial Owner of more than 10% of a Class of Security — 2024-08-06 00:00:00 I
6 11703 55238 — Purchase at price 4.72 per share. FRIEDBERG ALBERT D Director and Beneficial Owner of more than 10% of a Class of Security — 2024-08-01 00:00:00 I
7 200000 1084201 — Purchase at price 5.10 - 5.74 per share. FRIEDBERG ALBERT D Director and Beneficial Owner of more than 10% of a Class of Security — 2024-07-31 00:00:00 I
8 1818 9210 — Purchase at price 4.95 - 5.20 per share. FRIEDBERG ALBERT D Director and Beneficial Owner of more than 10% of a Class of Security — 2024-05-30 00:00:00 I
9 543 3122 — Stock Award(Grant) at price 5.75 per share. VAN STRYDONCK GERALD E Director — 2024-05-10 00:00:00 D
Financials
Line Item2024-12-312023-12-312022-12-312021-12-31
TaxEffectOfUnusualItems0.000.000.000.00
TaxRateForCalcs0.000.000.000.00
NormalizedEBITDA-18.60M-21.85M-19.61M-22.28M
TotalUnusualItems62.00K1.72M0.00876.00K
TotalUnusualItemsExcludingGoodwill62.00K1.72M0.00876.00K
NetIncomeFromContinuingOperationNetMinorityInterest-18.63M-20.25M-19.82M-22.38M
ReconciledDepreciation94.00K119.00K207.00K169.00K
ReconciledCostOfRevenue0.00
EBITDA-18.54M-20.13M-19.61M-21.40M
EBIT-18.63M-20.25M-19.81M-21.57M
NetInterestIncome-2.00K-1.00K-2.00K-809.00K
InterestExpense2.00K1.00K2.00K809.00K
NormalizedIncome-18.70M-21.97M-19.82M-23.26M
NetIncomeFromContinuingAndDiscontinuedOperation-18.63M-20.25M-19.82M-22.38M
TotalExpenses19.34M23.45M20.18M23.39M
TotalOperatingIncomeAsReported-18.73M-22.89M-19.91M-22.49M
DilutedAverageShares463.65K202.08K137.38K
BasicAverageShares463.65K202.08K137.38K
DilutedEPS-43.68-98.05-163.80
BasicEPS-43.68-98.05-163.80
DilutedNIAvailtoComStockholders-18.63M-20.25M-19.82M-22.38M
NetIncomeCommonStockholders-18.63M-20.25M-19.82M-22.38M
NetIncome-18.63M-20.25M-19.82M-22.38M
MinorityInterests0.00
NetIncomeIncludingNoncontrollingInterests-18.63M-20.25M-19.82M-22.38M
NetIncomeContinuousOperations-18.63M-20.25M-19.82M-22.38M
TaxProvision0.000.000.000.00
PretaxIncome-18.63M-20.25M-19.82M-22.38M
OtherIncomeExpense103.00K2.63M93.00K919.00K
OtherNonOperatingIncomeExpenses41.00K912.00K93.00K43.00K
SpecialIncomeCharges0.00876.00K
OtherSpecialCharges-876.00K
GainOnSaleOfSecurity62.00K1.72M
NetNonOperatingInterestIncomeExpense-2.00K-1.00K-2.00K-809.00K
InterestExpenseNonOperating2.00K1.00K2.00K809.00K
OperatingIncome-18.73M-22.89M-19.91M-22.49M
OperatingExpense19.34M23.45M20.18M23.39M
OtherOperatingExpenses-175.00K
ResearchAndDevelopment12.54M16.57M13.98M17.16M
SellingGeneralAndAdministration6.79M6.88M6.20M6.23M
GeneralAndAdministrativeExpense6.79M6.88M6.20M6.23M
OtherGandA6.79M6.88M6.20M6.23M
GrossProfit900.00K
CostOfRevenue0.00
TotalRevenue601.00K570.00K275.00K900.00K
OperatingRevenue601.00K570.00K275.00K900.00K
Line Item2024-12-312023-12-312022-12-312021-12-31
TreasurySharesNumber5.004.004.004.00
OrdinarySharesNumber2.68M892.62K237.53K146.67K
ShareIssued2.68M892.62K237.53K146.68K
TotalDebt25.00K247.00K485.00K390.00K
TangibleBookValue-4.15M-2.31M5.19M7.41M
InvestedCapital-4.13M-2.21M5.37M7.66M
WorkingCapital-2.55M-2.57M4.94M7.15M
NetTangibleAssets-2.49M-2.31M5.19M7.41M
CapitalLeaseObligations0.00146.00K310.00K141.00K
CommonStockEquity-4.15M-2.31M5.19M7.41M
PreferredStockEquity1.67M
TotalCapitalization-2.49M-2.29M5.29M7.59M
TotalEquityGrossMinorityInterest-2.49M-2.31M5.19M7.41M
MinorityInterest0.00
StockholdersEquity-2.49M-2.31M5.19M7.41M
TreasuryStock11.00K11.00K11.00K11.00K
RetainedEarnings-358.56M-339.93M-319.68M-299.86M
AdditionalPaidInCapital354.42M337.63M324.88M307.28M
CapitalStock1.67M0.000.003.00K
CommonStock1.00K0.000.003.00K
PreferredStock1.67M0.00
TotalLiabilitiesNetMinorityInterest5.08M5.94M2.78M2.43M
TotalNonCurrentLiabilitiesNetMinorityInterest0.0026.00K247.00K175.00K
LongTermDebtAndCapitalLeaseObligation26.00K247.00K175.00K
LongTermCapitalLeaseObligation0.00146.00K0.00
LongTermDebt26.00K101.00K175.00K
CurrentLiabilities5.08M5.92M2.54M2.26M
OtherCurrentLiabilities2.35M
CurrentDeferredLiabilities0.0063.00K0.00
CurrentDeferredRevenue0.0063.00K0.00
CurrentDebtAndCapitalLeaseObligation25.00K221.00K238.00K215.00K
CurrentCapitalLeaseObligation0.00146.00K164.00K141.00K
CurrentDebt25.00K75.00K74.00K74.00K
OtherCurrentBorrowings25.00K75.00K74.00K74.00K
PayablesAndAccruedExpenses5.06M3.28M2.30M2.04M
CurrentAccruedExpenses1.10M1.24M781.00K980.00K
InterestPayable0.00
Payables3.96M2.04M1.52M1.06M
AccountsPayable3.96M2.04M1.52M1.06M
TotalAssets2.60M3.63M7.98M9.84M
TotalNonCurrentAssets65.00K283.00K499.00K438.00K
NetPPE65.00K283.00K499.00K438.00K
AccumulatedDepreciation-7.18M-7.09M-7.26M-7.05M
GrossPPE7.25M7.37M7.75M7.49M
Leases3.28M3.28M3.26M3.21M
OtherProperties3.37M3.50M3.83M3.64M
MachineryFurnitureEquipment600.00K600.00K671.00K634.00K
Properties0.000.000.000.00
CurrentAssets2.53M3.35M7.48M9.40M
OtherCurrentAssets586.00K853.00K912.00K816.00K
HedgingAssetsCurrent0.000.00
PrepaidAssets816.00K
Receivables838.00K961.00K175.00K0.00
AccountsReceivable838.00K961.00K175.00K0.00
CashCashEquivalentsAndShortTermInvestments1.11M1.53M6.39M8.59M
CashAndCashEquivalents1.11M1.53M6.39M8.59M
Line Item2024-12-312023-12-312022-12-312021-12-31
FreeCashFlow-16.21M-21.45M-19.17M-25.33M
RepaymentOfDebt-76.00K-74.00K-75.00K-8.54M
IssuanceOfDebt0.00
IssuanceOfCapitalStock8.82M12.27M17.05M32.85M
CapitalExpenditure-22.00K-67.00K-99.00K-32.00K
EndCashPosition1.11M1.53M6.39M8.59M
BeginningCashPosition1.53M6.39M8.59M10.60M
ChangesInCash-428.00K-4.86M-2.20M-2.01M
FinancingCashFlow15.78M16.59M16.98M23.32M
CashFlowFromContinuingFinancingActivities15.78M16.59M16.98M23.32M
NetOtherFinancingCharges-985.00K
ProceedsFromStockOptionExercised7.03M4.39M0.00
NetPreferredStockIssuance1.70M0.00
PreferredStockIssuance1.70M0.00
NetCommonStockIssuance7.12M12.27M17.05M32.85M
CommonStockIssuance7.12M12.27M17.05M32.85M
NetIssuancePaymentsOfDebt-76.00K-74.00K-75.00K-8.54M
NetLongTermDebtIssuance-76.00K-74.00K-75.00K-8.54M
LongTermDebtPayments-76.00K-74.00K-75.00K-8.54M
LongTermDebtIssuance0.00
InvestingCashFlow-22.00K-67.00K-99.00K-32.00K
CashFlowFromContinuingInvestingActivities-22.00K-67.00K-99.00K-32.00K
NetPPEPurchaseAndSale-22.00K-67.00K-99.00K-32.00K
PurchaseOfPPE-22.00K-67.00K-99.00K-32.00K
OperatingCashFlow-16.19M-21.38M-19.07M-25.30M
CashFlowFromContinuingOperatingActivities-16.19M-21.38M-19.07M-25.30M
ChangeInWorkingCapital2.10M318.00K-11.00K-3.21M
ChangeInOtherWorkingCapital-63.00K63.00K
ChangeInPayablesAndAccruedExpense1.78M982.00K258.00K-3.06M
ChangeInAccruedExpense-138.00K461.00K-199.00K-957.00K
ChangeInPayable1.91M521.00K457.00K-2.11M
ChangeInAccountPayable1.91M521.00K457.00K-2.11M
ChangeInPrepaidAssets267.00K59.00K-94.00K-302.00K
ChangeInReceivables123.00K-786.00K-175.00K157.00K
ChangesInAccountReceivables123.00K-786.00K-175.00K157.00K
OtherNonCashItems-1.29M-2.11M458.00K
StockBasedCompensation341.00K474.00K545.00K541.00K
DepreciationAmortizationDepletion94.00K119.00K207.00K169.00K
DepreciationAndAmortization94.00K119.00K207.00K169.00K
Depreciation94.00K119.00K207.00K169.00K
OperatingGainsLosses1.20M67.00K-876.00K
GainLossOnInvestmentSecurities1.20M67.00K
NetIncomeFromContinuingOperations-18.63M-20.25M-19.82M-22.38M
SEC Filings

Recent 10-K, 10-Q, 8-K, and Form 4 (insider) filings.

Public Trades for VCNX
Date User Asset Broker Type Position Size Entry Price Patterns